The French laboratory Xenothera has developed a treatment that it considers effective against the new coronavirus as well as all its different variants.
Called XAV-19, this treatment is a polyclonal antibody directed against the SARS-CoV-2 virus. It is, according to the laboratory, effective in patients with moderate form of the disease.
Live from Nantes, the president of the Xenothera laboratory, Dr. Odile Duvaux talks about this treatment and explains how it works. More details in this excerpt.
– .
